52,645.45
(15.54)
(0.02%)
28 Aug , 2026 | 10:54 AM
Open
52,732.85
Prev. Close
52,629.9
Market Cap.
₹0
Div Yield
0.3
PE
45.1
PB
45.1
52,545.75
52,920.1
Performance
One Week (%)
1.38
One Month (%)
2.58
One Year (%)
21.07
YTD (%)
25.23
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,510 | 26,745 | 26,350 | 1,759 |
Glaxosmithkline Pharmaceuticals Ltd | 3,105.5 | 3,115 | 3,052.7 | 19,194 |
Pfizer Ltd | 4,767.9 | 4,778.4 | 4,732.6 | 3,030 |
Lupin Ltd | 2,165.9 | 2,172 | 2,153 | 66,401 |
Ipca Laboratories Ltd | 1,952.8 | 1,977.3 | 1,935.6 | 94,198 |
Neuland Laboratories Ltd | 23,328 | 23,876 | 23,220 | 19,558 |
Aurobindo Pharma Ltd | 1,634.6 | 1,643.9 | 1,620.1 | 1,36,247 |
Natco Pharma Ltd | 852.4 | 861 | 844.85 | 1,86,374 |
Wockhardt Ltd | 2,016.5 | 2,045 | 1,973.1 | 8,93,977 |
Granules India Ltd | 836 | 844 | 833.5 | 42,808 |
Ajanta Pharma Ltd | 3,546.5 | 3,596 | 3,542 | 8,453 |
Poly Medicure Ltd | 1,684.1 | 1,712.9 | 1,683.5 | 39,626 |
Gland Pharma Ltd | 2,860.7 | 2,894.5 | 2,858.8 | 36,734 |
Biocon Ltd | 416.15 | 418.65 | 415.1 | 3,48,957 |
Alkem Laboratories Ltd | 5,374.5 | 5,390 | 5,316 | 17,168 |
Glenmark Pharmaceuticals Ltd | 2,437.1 | 2,472 | 2,431.7 | 1,08,509 |
Fortis Healthcare Ltd | 927.65 | 933.95 | 916.05 | 4,46,527 |
Syngene International Ltd | 409.65 | 417.9 | 409.25 | 79,703 |
Global Health Ltd | 1,515.1 | 1,531.4 | 1,496.1 | 1,70,901 |
Krishna Institute of Medical Sciences Ltd | 772.75 | 785.6 | 772 | 1,83,225 |
Mankind Pharma Ltd | 2,393.8 | 2,422.1 | 2,390 | 45,262 |
Dr Lal Pathlabs Ltd | 1,926.3 | 1,946.8 | 1,924 | 18,670 |
Narayana Hrudayalaya Ltd | 1,923.9 | 1,930 | 1,905.9 | 63,443 |
Laurus Labs Ltd | 1,918.5 | 1,929.9 | 1,911 | 7,71,419 |
Sai Life Sciences Ltd | 1,493.1 | 1,506.3 | 1,483 | 94,443 |
Aster DM Quality Care Ltd | 748.7 | 765 | 747.7 | 4,29,098 |
Acutaas Chemicals Ltd | 3,275 | 3,384 | 3,254 | 93,450 |
Cohance Lifesciences Ltd | 450.3 | 454.75 | 448.8 | 1,17,237 |
Piramal Pharma Ltd | 217.52 | 219.77 | 214.61 | 23,82,536 |
OneSource Specialty Pharma Ltd | 1,527 | 1,534.5 | 1,520 | 7,563 |
Sensex and Nifty 50 remain under pressure on August 19, 2026, extending their losing streak amid rising crude oil prices, Strait of Hormuz tensions, higher US Treasury yields, rupee weakness and continued FPI concerns.
19 Aug 2026|11:55 AM
Indian stock markets traded lower on August 18, 2026, as rising crude oil prices, US-Iran tensions, higher global bond yields and rupee weakness triggered a risk-off mood. Nifty 50 fell to 24,177.20 by 11:30 AM, while investors tracked NSE IPO developments, Lalithaa Jewellery Mart IPO subscription, ICICI Bank and key corporate updates.
18 Aug 2026|11:45 AM
Indian benchmark indices ended sharply higher on August 3, with the Sensex gaining 544 points and the Nifty closing at 24,774. Strong buying in IT stocks, easing crude oil prices, improving FII sentiment, and the rollout of the new Closing Auction Session (CAS) drove the rally, while investors remained focused on the upcoming RBI policy meeting.
3 Aug 2026|05:57 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
